Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Chronic Cough: 50 Patient Proof of Concept Study Completed in 10 Months in UK.

https://www.businesswire.com/news/home/20220629005372/en/Axalbion-Announces-Positive-Findings-from-Phase-2-Clinical-Study-in-Chronic-Cough-with-AX-8-a-Novel-TRPM8-Agonist

https://clinicaltrials.gov/ct2/show/NCT04866563

Jacky Smith (Principle Investigator) is on the Advisory Board of both Algernon Pharmaceuticals and Bellus Health, and likely other companies. She's a hired gun for Chronic Cough. It would appear that Algernon is the only company that struggles enormously to get to data results. It has everything to do with location and cheap tricks. Will management ever change their wicked ways?

https://algernonpharmaceuticals.com/medical-and-scientific-advisory-board/

https://bellushealth.com/about-us/our-company/#chronic-cough-cab

"“We look forward to testing AX-8 in this proof-of-concept study, as there are currently no approved treatments for chronic cough. By activating TRPM8, our goal is to decrease the upper airway sensitivity in chronic cough patients, and reduce coughing and throat irritation,” said principal investigator Jacky Smith, MD, professor of respiratory medicine at the University of Manchester, UK."

https://WWW.BUSINESSWIRE.COM/news/home/20211020005271/en/Axalbion-Announces-First-Patients-Treated-in-Phase-2-Clinical-Trial-in-Chronic-Cough-with-AX-8-a-Novel-TRPM8-Agonist

https://axalbion.com/

M$